My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 417

    1.

    Serum adiponectin is increased in type 1 diabetic patients with nephropathy.

    Saraheimo M, Forsblom C, Fagerudd J, Teppo AM, Pettersson-Fernholm K, Frystyk J, Flyvbjerg A, Groop PH; FinnDiane study group.

    Diabetes Care. 2005 Jun;28(6):1410-4.PMID: 15920060 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.

    Saraheimo M, Forsblom C, Thorn L, Wadén J, Rosengård-Bärlund M, Heikkilä O, Hietala K, Gordin D, Frystyk J, Flyvbjerg A, Groop PH; FinnDiane Study Group.

    Diabetes Care. 2008 Jun;31(6):1165-9. Epub 2008 Mar 17.PMID: 18346990 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy.

    Saraheimo M, Forsblom C, Hansen TK, Teppo AM, Fagerudd J, Pettersson-Fernholm K, Thiel S, Tarnow L, Ebeling P, Flyvbjerg A, Groop PH; FinnDiane Study Group.

    Diabetologia. 2005 Jan;48(1):198-202. Epub 2004 Dec 23.PMID: 15616805 [PubMed - indexed for MEDLINE]Related articles

    4.

    Increased serum high-molecular-weight complex of adiponectin in type 2 diabetic patients with impaired renal function.

    Komaba H, Igaki N, Goto S, Yokota K, Doi H, Takemoto T, Kohno M, Hirosue Y, Goto T.

    Am J Nephrol. 2006;26(5):476-82. Epub 2006 Nov 7.PMID: 17095862 [PubMed - indexed for MEDLINE]Related articles

    5.

    Increased levels of alpha-defensin (-1, -2 and -3) in type 1 diabetic patients with nephropathy.

    Saraheimo M, Forsblom C, Pettersson-Fernholm K, Flyvbjerg A, Groop PH, Frystyk J; FinnDiane Study Group.

    Nephrol Dial Transplant. 2008 Mar;23(3):914-8. Epub 2007 Nov 14.PMID: 18003664 [PubMed - indexed for MEDLINE]Related articles

    6.

    Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy.

    Fujita H, Morii T, Koshimura J, Ishikawa M, Kato M, Miura T, Sasaki H, Narita T, Ito S, Kakei M.

    Endocr J. 2006 Dec;53(6):745-52. Epub 2006 Sep 12.PMID: 16966829 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes.

    Nakamura A, Shikata K, Hiramatsu M, Nakatou T, Kitamura T, Wada J, Itoshima T, Makino H.

    Diabetes Care. 2005 Dec;28(12):2890-5.PMID: 16306550 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients.

    Saraheimo M, Teppo AM, Forsblom C, Fagerudd J, Groop PH.

    Diabetologia. 2003 Oct;46(10):1402-7. Epub 2003 Aug 20.PMID: 12928771 [PubMed - indexed for MEDLINE]Related articles

    9.

    Renal function in long-duration type I diabetes.

    Mackin P, Macleod JM, New JP, Marshall SM.

    Diabetes Care. 1996 Mar;19(3):249-51.PMID: 8742571 [PubMed - indexed for MEDLINE]Related articles

    10.

    Pulmonary dysfunction in type 1 diabetes in relation to metabolic long-term control and to incipient diabetic nephropathy.

    Schnack C, Festa A, Schwarzmaier-D'Assié A, Haber P, Schernthaner G.

    Nephron. 1996;74(2):395-400.PMID: 8893162 [PubMed - indexed for MEDLINE]Related articles

    11.

    Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study).

    Thorn LM, Forsblom C, Fagerudd J, Thomas MC, Pettersson-Fernholm K, Saraheimo M, Wadén J, Rönnback M, Rosengård-Bärlund M, Björkesten CG, Taskinen MR, Groop PH; FinnDiane Study Group.

    Diabetes Care. 2005 Aug;28(8):2019-24.PMID: 16043748 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration.

    Chiarelli F, Cipollone F, Romano F, Tumini S, Costantini F, di Ricco L, Pomilio M, Pierdomenico SD, Marini M, Cuccurullo F, Mezzetti A.

    Diabetes. 2000 Jul;49(7):1258-63.PMID: 10909986 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects.

    Hadjadj S, Aubert R, Fumeron F, Pean F, Tichet J, Roussel R, Marre M; SURGENE Study Group; DESIR Study Group.

    Diabetologia. 2005 Jun;48(6):1088-92. Epub 2005 May 5.PMID: 15875155 [PubMed - indexed for MEDLINE]Related articles

    14.

    Regression of microalbuminuria in type 1 diabetic patients: results of a sequential intervention with improved metabolic control and ACE inhibitors.

    Vilarrasa N, Soler J, Montanya E.

    Acta Diabetol. 2005 Jun;42(2):87-94.PMID: 15944842 [PubMed - indexed for MEDLINE]Related articles

    15.

    Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function.

    Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A, Fouque D.

    Nephrol Dial Transplant. 2005 Jan;20(1):129-34. Epub 2004 Dec 7.PMID: 15585515 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Plasma levels of AGE peptides in type 1 diabetic patients are associated with serum creatinine and not with albumin excretion rate: possible role of AGE peptide-associated endothelial dysfunction.

    Schalkwijk CG, Ter Wee PM, Stehouwer CD.

    Ann N Y Acad Sci. 2005 Jun;1043:662-70.PMID: 16037290 [PubMed - indexed for MEDLINE]Related articles

    17.

    The 10-year incidence of renal insufficiency in people with type 1 diabetes.

    Klein R, Klein BE, Moss SE, Cruickshanks KJ, Brazy PC.

    Diabetes Care. 1999 May;22(5):743-51.PMID: 10332675 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy.

    Nguyen TQ, Tarnow L, Andersen S, Hovind P, Parving HH, Goldschmeding R, van Nieuwenhoven FA.

    Diabetes Care. 2006 Jan;29(1):83-8.PMID: 16373901 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy.

    Yokoyama H, Jensen JS, Jensen T, Deckert T.

    J Intern Med. 1995 May;237(5):519-23.PMID: 7738493 [PubMed - indexed for MEDLINE]Related articles

    20.

    The impact of metabolic and blood pressure control on incidence and progression of nephropathy. A 10-year study of 385 type 2 diabetic patients.

    Torffvit O, Agardh CD.

    J Diabetes Complications. 2001 Nov-Dec;15(6):307-13.PMID: 11711324 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity